We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Seed Innovations Limited (SEED) Ordinary 1p

Sell:1.40p Buy:1.50p 0 Change: No change
Market closed Prices as at close on 4 October 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1.40p
Buy:1.50p
Change: No change
Market closed Prices as at close on 4 October 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1.40p
Buy:1.50p
Change: No change
Market closed Prices as at close on 4 October 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Objective

To invest in disruptive technologies with significant intellectual property rights which they are seeking to exploit, principally within the technology sector, life sciences sectors and health and wellness sectors. This includes investing in the cannabinoid secto. The Company main geographical focus will be in North America and Europe though investments may also be considered in other regions to the extent that the Board considers that valuable opportunities exist, and positive returns can be achieved.
Security Weight
Fralis Llc (Leap Gaming) 40.34%
Eurox Group Gmbh 20.88%
Juvenescence Ltd 11.75%
Little Green Pharma 9.89%
Northern Leaf Ltd 3.22%
Inveniam Capital Partners 2.74%
South West Brands 2.32%
Yooma Wellness Inc 1.71%
Portage Biotech Inc. 1.22%
Cii Tech Limited 0.92%

Top 10 sectors currently unavailable.

Top 10 countries currently unavailable.

Fee Structure

The Company is self-managed, in that day-to-day investment management recommendations are made by the Executive Director.

Dividend Policy

It is not expected that the Company will pay an annual dividend.

ASSET SPLIT

Total number of holdings: 2.

Trust Manager

Not Disclosed

Manager Bio

Not currently available for this investment trust.

Board Of Directors

Ian BurnsChairman, Edward McDermott, Luke Cairns, Lance De Jersey, Alfredo Romero

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.